Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Inovio Pharma (INO)
Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 103,189
  • Shares Outstanding, K 272,986
  • Annual Sales, $ 10,260 K
  • Annual Income, $ -279,820 K
  • 60-Month Beta 0.99
  • Price/Sales 10.10
  • Price/Cash Flow N/A
  • Price/Book 0.77
Trade INO with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.59
  • Most Recent Earnings -0.09 on 11/09/23
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 53.01%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 1,391.46% on 08/14/23
  • IV Low 0.00% on 12/08/23
  • Put/Call Vol Ratio 0.03
  • Today's Volume 78
  • Volume Avg (30-Day) 169
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 36,779
  • Open Int (30-Day) 36,781

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.11
  • Number of Estimates 3
  • High Estimate -0.08
  • Low Estimate -0.15
  • Prior Year -0.21
  • Growth Rate Est. (year over year) +47.62%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3240 +17.72%
on 11/10/23
0.4300 -11.30%
on 11/20/23
+0.0014 (+0.37%)
since 11/08/23
3-Month
0.3240 +17.72%
on 11/10/23
0.5933 -35.72%
on 10/10/23
-0.0706 (-15.62%)
since 09/08/23
52-Week
0.3240 +17.72%
on 11/10/23
1.9900 -80.83%
on 01/13/23
-1.4586 (-79.27%)
since 12/08/22

Most Recent Stories

More News
3 Biotech Stocks to Watch in November

The biotech industry’s expansion stems from advancements in bio-medical drug development and cutting-edge technology. Given these factors, prominent biotech stocks Inovio Pharmaceuticals (INO), Surrozen...

GMAB : 32.24 (-0.37%)
INO : 0.3804 (+0.63%)
SRZN : 0.5501 (+1.72%)
Inovio Pharmaceuticals (INO) Q3 2023 Earnings Call Transcript

INO earnings call for the period ending September 30, 2023.

INO : 0.3804 (+0.63%)
Inovio: Q3 Earnings Snapshot

Inovio: Q3 Earnings Snapshot

INO : 0.3804 (+0.63%)
INOVIO Announces U.S. FDA Breakthrough Therapy Designation Granted for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis

/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

INO : 0.3804 (+0.63%)
Inovio Pharmaceuticals (INO) Q2 2023 Earnings Call Transcript

INO earnings call for the period ending June 30, 2023.

INO : 0.3804 (+0.63%)
Inovio: Q2 Earnings Snapshot

Inovio: Q2 Earnings Snapshot

INO : 0.3804 (+0.63%)
INOVIO Announces Second Quarter 2023 Financial Results and Provides Strategic Update

Preparing to initiate pivotal Phase 3 trial of INO-3107 in adult RRP patients in first quarter of 2024; INO-3107 received Orphan Drug Designation from European...

INO : 0.3804 (+0.63%)
INOVIO Reports Inducement Grants Under Inducement Plan

/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

INO : 0.3804 (+0.63%)
INOVIO to Report Second Quarter 2023 Financial Results on August 9, 2023

/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

INO : 0.3804 (+0.63%)
INOVIO to Present at the 2023 Jefferies Healthcare Conference

/PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

INO : 0.3804 (+0.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Inovio Pharmaceuticals, Inc., formerly known as Inovio Biomedical Corporation, is engaged in the discovery, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The Company's electroporation DNA delivery technology uses brief, controlled...

See More

Key Turning Points

3rd Resistance Point 0.3853
2nd Resistance Point 0.3827
1st Resistance Point 0.3803
Last Price 0.3804
1st Support Level 0.3753
2nd Support Level 0.3727
3rd Support Level 0.3703

See More

52-Week High 1.9900
Fibonacci 61.8% 1.3536
Fibonacci 50% 1.1570
Fibonacci 38.2% 0.9604
Last Price 0.3804
52-Week Low 0.3240

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar